The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concurrent versus sequential neoadjuvant chemoradiation therapy for esophageal and gastroesophageal junction adenocarcinoma.
 
Robert J. Torphy
No Relationships to Disclose
 
Felix Ho
No Relationships to Disclose
 
Chloe Friedman
No Relationships to Disclose
 
Stephen Leong
Stock and Other Ownership Interests - Antares Pharmaceuticals; Antares Pharmaceuticals; Antares Pharmaceuticals; Antares Pharmaceuticals; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals
Honoraria - Lilly; Lilly; Lilly; Lilly
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Deciphera (Inst); Deciphera (Inst); Deciphera (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
 
Sachin Wani
No Relationships to Disclose
 
Christopher D. Scott
No Relationships to Disclose
 
Michael J. Weyant
Consulting or Advisory Role - Covidien; Covidien; Covidien; Covidien; Myriad Pharmaceuticals; Myriad Pharmaceuticals; Myriad Pharmaceuticals; Myriad Pharmaceuticals
 
Robert A. Meguid
No Relationships to Disclose
 
Ana Gleisner
No Relationships to Disclose
 
Karyn A. Goodman
Consulting or Advisory Role - RenovoRx; RenovoRx; RenovoRx; RenovoRx
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
 
Martin D. McCarter
No Relationships to Disclose